Abstract
Liver cirrhosis and hepatocellular carcinoma disease caused by the Hepatitis C virus (HCV) infection. Inside this article, a deterministic model has been formulated and analyzed for the transmission of HCV in the liver cells. We have also considered two types of viral strain (wild and mutant). We have also projected a mathematical model of the effect of Sofosbuvir (SOF) together with Velpatasvir (VEL) antiviral therapy in HCV infected patients. Our analytical and numerical findings reveal that the optimal schedule of treatment for the best result should be obtained by choosing the best strategy depending on the circumstances.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.